PINK SIMPLIFY HEALTH CARE ETF
- 30.176
- +0.150+0.50%
US stocks closed | Non-farm employment was hit hard and interest rate expectations fell, with all three major indexes falling collectively. Gamestop plummeted nearly 40%.
After the US employment report, US bond yields rose more than 10 basis points; the US dollar index, which had approached its two-month low, rose sharply and hit a new high in more than a week; offshore renminbi fell 180 points and lost 7.26. Bitcoin dropped more than $3,000, approaching the $72,000 mark in intraday trading.
Catalyst Watch: Apple's WWDC, Tesla's Annual Meeting, Fed's Dot Plot, and GameStop Volatility
7 Actionable Trading Ideas - Piper Sandler
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Jefferies Maintains Buy on Eli Lilly and Co, Raises Price Target to $957
Jefferies analyst Akash Tewari maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $925 to $957.
Eli Lilly and Co Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/07/2024 12.05% Jefferies $925 → $957 Maintains Buy 05/14/2024 -1.65% Argus Research $770 → $840 Maintai
CNBC Halftime Report Final Trades: Nike, Merck & Company, General Motors, SPDR Select Sector Fund - Energy Select Sector
CNBC Halftime Report Final Trades: Nike, Merck & Company, General Motors, SPDR Select Sector Fund - Energy Select Sector
Ocean Power Fails to Engage in Good Faith With Paragon Creating Going Concern Issues and Risk for the Company and Its Shareholders
EASTON, PA / ACCESSWIRE / June 7, 2024 / Paragon Technologies, Inc. ("Paragon"), a diversified holding company and a large shareholder of Ocean Power Technologies, Inc. (NYSE American:OPTT), ("Company
Rapport Therapeutics Starts Trading Above IPO Price
Over 10,000 Lawsuits In Novo Nordisk's Ozempic Case Assigned to New Judge
U.S. District Judge Karen Marston in Philadelphia is set to preside over litigation involving the popular diabetes and weight-loss drugs Ozempic, Wegovy, and Mounjaro.The Judicial Panel on Multidistri
Kroger Follows Costco to Offer GLP-1s as Part of Weight Loss Program
Wall Street Reacts To Hot Jobs Report: Stocks Swing As Traders Abandon July Rate Cut Hopes
The May labor market report delivered hotter-than-expected numbers in terms of job gains and wage growth.Last month, U.S. employers added 272,000 nonfarm payrolls, a sharp increase from April's 165,00
FDA Advised Manufacturers Of Authorized Covid Vaccines That Covid-19 Vaccines For Use Beginning In Fall 2024 Should Be Monovalent JN.1 Vaccines
FDA Advised Manufacturers Of Authorized Covid Vaccines That Covid-19 Vaccines For Use Beginning In Fall 2024 Should Be Monovalent JN.1 Vaccines
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
With more than 10% of the global population now suffering from obesity, the share prices of companies providing the latest weight-loss drugs have surged.However, according to industry observers, inves
Ozempic, Wegovy Create Domino Effect As New Products Emerge Across Industries To Capture New Consumer Habits
The rise of weight loss drugs like Wegovy and Mounjaro by Novo Nordisk (NYSE:NVO) is leading to new product developments across various sectors.What Happened: Companies from food and beverage to fitne
Halozyme Downgraded at Piper Sandler Despite Guidance Raise
UnitedHealth Declares $2.10 Dividend
J&J Cleared to Expand Use of Velys Robotic System in U.S.
3M Shares Are Trading Higher After B of A Securities Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $105 to $120.
3M Shares Are Trading Higher After B of A Securities Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $105 to $120.
3M Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/07/2024 19.69% B of A Securities $105 → $120 Upgrades Neutral → Buy 05/28/2024 17.69% Barclays $112 → $